CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-18 | Christmas Patrick J. SVP, General Counsel | Sale | −90 | $62.67 | $6K | 17,669 |
| 2018-10-18 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,000 | 58,472 | ||
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +46,517 | $22.00 | $1.0M | 86,017 |
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Sale | −46,517 | $60.85 | $2.8M | 39,500 |
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +13,125 | $19.50 | $256K | 52,625 |
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Sale | −13,125 | $60.85 | $799K | 39,500 |
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +2,667 | $13.09 | $35K | 42,167 |
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Sale | −2,667 | $60.85 | $162K | 39,500 |
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −46,517 | 108,983 | ||
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −13,125 | 16,875 | ||
| 2018-10-16 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −2,667 | 3,333 | ||
| 2018-10-16 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +10,414 | $0.85 | $9K | 10,414 |
| 2018-10-16 | Yoo Stephen Chief Medical Officer | Sale | −10,414 | $61.18 | $637K | 0 |
| 2018-10-16 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,414 | 122,486 | ||
| 2018-10-15 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +10,000 | $0.85 | $9K | 10,000 |
| 2018-10-15 | Yoo Stephen Chief Medical Officer | Sale | −2,900 | $58.83 | $171K | 7,100 |
| 2018-10-15 | Yoo Stephen Chief Medical Officer | Sale | −7,000 | $59.54 | $417K | 100 |
| 2018-10-15 | Yoo Stephen Chief Medical Officer | Sale | −100 | $60.25 | $6K | 0 |
| 2018-10-15 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 132,900 | ||
| 2018-10-15 | Vasista Vittal Chief Financial Officer | Sale | −2,500 | $58.93 | $147K | 142,283 |
Page 37 of 43 · 852 trades